Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue

Jens O. Watzlawik,Xu Hou,Tyrique Richardson,Szymon L. Lewicki,Joanna Siuda,Zbigniew K. Wszolek,Casey N. Cook,Leonard Petrucelli,Michael DeTure,Dennis W. Dickson,Odetta Antico,Miratul M. K. Muqit,Jordan B. Fishman,Karima Pirani,Ravindran Kumaran,Nicole K. Polinski,Fabienne C. Fiesel,Wolfdieter Springer

DOI: https://doi.org/10.1101/2024.01.15.575715

2024-01-16

Abstract:The selective removal of dysfunctional mitochondria, a process termed mitophagy, is critical for cellular health and impairments have been linked to aging, Parkinson disease, and other neurodegenerative conditions. A central mitophagy pathway is orchestrated by the ubiquitin (Ub) kinase PINK1 together with the E3 Ub ligase PRKN/Parkin. The decoration of damaged mitochondrial domains with phosphorylated Ub (p-S65-Ub) mediates their elimination though the autophagy system. As such p-S65-Ub has emerged as a highly specific and quantitative marker of mitochondrial damage with significant disease relevance. Existing p-S65-Ub antibodies have been successfully employed as research tools in a range of applications including western blot, immunocytochemistry, immunohistochemistry, and ELISA. However, physiological levels of p-S65-Ub in the absence of exogenous stress are very low, therefore difficult to detect and require reliable and ultrasensitive methods. Here we generated and characterized a collection of novel recombinant, rabbit monoclonal p-S65-Ub antibodies with high specificity and affinity in certain applications that allow the field to better understand the molecular mechanisms and disease relevance of PINK1-PRKN signaling. These antibodies may also serve as novel diagnostic or prognostic tools to monitor mitochondrial damage in various clinical and pathological specimens.

Neuroscience